Compare INSM & RS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSM | RS |
|---|---|---|
| Founded | 1988 | 1939 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.4B | 19.4B |
| IPO Year | 2000 | 1996 |
| Metric | INSM | RS |
|---|---|---|
| Price | $118.52 | $387.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 6 |
| Target Price | $201.17 | ★ $358.00 |
| AVG Volume (30 Days) | ★ 2.9M | 322.1K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 5.10 |
| Revenue | N/A | ★ $14,805,900,000.00 |
| Revenue This Year | $182.31 | $10.16 |
| Revenue Next Year | $65.19 | $0.82 |
| P/E Ratio | ★ N/A | $76.80 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $90.39 | $260.31 |
| 52 Week High | $212.75 | $433.02 |
| Indicator | INSM | RS |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 43.08 |
| Support Level | $97.66 | $390.05 |
| Resistance Level | $119.54 | $419.83 |
| Average True Range (ATR) | 4.08 | 12.47 |
| MACD | -1.32 | -3.80 |
| Stochastic Oscillator | 2.22 | 20.48 |
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
Reliance Inc operates a network of companies providing diversified metal solutions and is the metals service center company. It distributes a full line of over 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium and other specialty steel products. The company services more than 125,000 customers in a variety of industries, including consumer products, general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, industrial machinery and heavy industry. It also services the auto industry, through its toll processing operations where it processes customer-owned metal for a fee.